Latest Breaking News On - Neurosense therapeutics ltd stock exchange - Page 2 : comparemela.com

By Denny Jacob NeuroSense Therapeutics Ltd. shares rocketed 283% to $5.97 after the company said it received clearance from the Food and Drug Administration to initiate a pharmacokinetic study. | March 21, 2022

Denny-jacob
Drug-administration
Neurosense-therapeutics-ltd
Sense-therapeutics
Dow-jones
Neurosense-therapeutics-ltd-stock-exchange
News
Information
Press-release
Y
Penny
Jacob